Jupiter Life Line Hospitals LtdNSE: JLHL
Open the Jupiter Life Line Hospitals Ltd page
Follow Jupiter Life Line Hospitals LtdFree account. Get a note when Jupiter Life Line Hospitals Ltd files.
Q1 FY27 results analysis · July 31, 2026

Jupiter Life Line Hospitals Ltd (JLHL) Q1 FY27 Results Analysis: PAT Slips 14.6%, Margin Pressure Persists

−14.6%PAT year on year, Rs. 37.49 Cr
Cofacto ResearchPublished July 31, 20262 min readNeutral read
Quick summary

Jupiter Life Line Hospitals Ltd's Q1 FY27 numbers came in mixed, with revenue of Rs. 410.98 Cr (+16.44% YoY) and PAT growth of -14.58% YoY. Here's a quick read of what worked, what to watch, and what management said.

Quick Details
Results dateJuly 31, 2026
QuarterQ1 FY 2026-2027
Revenue (Q1)Rs. 410.98 Cr (+16.44% YoY)
PAT (Q1)Rs. 37.49 Cr (-14.58% YoY)
EBITDA margin19.29% (-293 bps YoY)
EPS (Q1)Rs. 5.72 (-14.50% YoY)
Market capRs. 10,870.84 Cr
CMPRs. 331.50

Quarter Snapshot

JLHL delivered strong revenue growth of 16.4% YoY, driven by the mature hospitals and the first full quarter from Dombivli. However, costs grew faster (22% YoY), compressing EBITDA margin by 293 bps and causing PAT to decline 14.6% YoY. The Dombivli ramp-up is on track as per management's guidance, but near-term margin pressure is expected to persist until occupancy improves.

Key Investment Insights

Key Positives

  • Revenue grew 16.4% YoY to Rs.410.98 Cr, with standalone mature hospitals growing 18.2% YoY
  • Dombivli contributed Rs.67 Cr revenue in its first full quarter, demonstrating early traction
  • Effective tax rate fell to 25.80% from 28.83% YoY, partially cushioning PAT decline
  • Leverage remains manageable at ~1.3x net debt/EBITDA, within the 3x ceiling
  • Auditor's report unmodified opinion on standalone and consolidated results

Risk Factors

  • EBITDA margin compressed 293 bps YoY to 19.29%, driven by cost growth outpacing revenue
  • PAT declined 14.6% YoY to Rs.37.49 Cr, despite revenue growth
  • Finance costs surged 55.5% YoY to Rs.12.86 Cr, reflecting higher debt for Dombivli
  • Professional fees grew 23.6% YoY and other expenses grew 26.3% YoY, both faster than revenue
  • Interest coverage compressed from ~9.5x to ~6.2x, increasing financial risk

Ask about this

Ask Cofacto a question about this result. Answers cite filings and company data.

Companies on this page

Related

Share on X · LinkedIn · WhatsApp

Disclaimer: This results analysis is published for educational and informational purposes only. It is not investment advice, not a recommendation to buy, sell or hold any security.